Investeringsforeningen ValueInvest Danmark – Prospektopdatering
Opdateret prospekt for Investeringsforeningen ValueInvest Danmark offentliggøres dags dato.
Der er foretaget følgende opdateringer i prospektet:
- Indsættelse af regnskabstal for 2023
Prospektet er vedhæftet denne fondsbørsmeddelelse og kan endvidere downloades på www.valueinvest.dk
eller rekvireres ved henvendelse til BI Management A/S, Bredgade 40, 1260 København K, tlf. 77 30 90 00.
Med venlig hilsen
BI Management A/S
Martin Fjordlund Smidt
Direktør
Vedhæftet fil
For at se dette indhold fra www.globenewswire.com, så skal du give din accept på toppen af denne side.For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.
Information om GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg pressemeddelelser fra GlobeNewswire by notified
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra GlobeNewswire by notified
XBP Europe Awarded a Transformation Project for His Majesty’s Passport Office (HMPO)2.5.2024 14:30:15 CEST | Press release
LONDON, May 02, 2024 (GLOBE NEWSWIRE) -- XBP Europe (“XBP Europe” or the “Company”) (NASDAQ: XBP and XBPEW), today announced that the Company has been selected by His Majesty’s Passport Office (“HMPO”) as its technology and services partner on a nationwide project, which aims to make documents dating back to 1837 digitally available to the General Register Office (“GRO”). This multi-year contract in the UK has an approximate total contract value of $40 million. A duty to the public The GRO, part of HMPO, maintains the national archive of births, marriages and deaths for England and Wales. This project is one strand of a wider transformation programme for GRO to update its systems and services. With some records dating back to 1837, the GRO faces significant document quality issues, which complicates the process of making them digital. Varied record formats must be handled, paper records are often faded, and microfilm can be of poor quality. The solution XBP Europe will use its hyper au
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med InterMail A/S' aktier2.5.2024 14:29:42 CEST | pressemeddelelse
Selskabsmeddelelse nr. 20 2023/24 2. maj 2024 Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med InterMail A/S' aktier InterMail A/S har dags dato modtaget meddelelser om transaktioner med selskabets aktier foretaget af ledende medarbejdere og/eller personer/selskaber der er nærtstående til disse. Der henvises til de vedhæftede filer. Venlig hilsen InterMail A/S Yderligere oplysninger: John Dueholm, Bestyrelsesformand Telefon: 31 24 49 31 E-mail: rdujdu@gmail.com InterMail er et datadrevet kommunikationshus, som rådgiver kunder i at skabe leads, salg samt øge kundeloyaliteten. Vi arbejder sammen med mere end 500 virksomheder, og hjælper dem med at skabe tydelige forretningsmæssige resultater på platforme som Google, Facebook, LinkedIn, Instagram samt via direct mails. Det kan vi fordi vi har erfarne og dygtige specialister med stor faglig ekspertise og mange års forretningsmæssig erfaring. Vedhæftede filer Selskabsmeddelelse 20 2023-24 - Indberetning af lede
Landsbankinn hf.: Financial results of Landsbankinn for the first three months of 20242.5.2024 14:25:23 CEST | Press release
Landsbankinn's net profit in the first three months of 2024 was ISK 7.2 billion.Return on equity (ROE) in the period was 9.3%, compared with 11.1% for the same period the previous year.The net interest margin was 2.9%. The net interest margin of domestic households was 2% and remains stable.Net interest income amounted to ISK 14.4 billion and net fee and commission income was ISK 2.7 billion.Net impairments were negative by ISK 2.7 billion and include an ISK 2.0 billion collective allowance against uncertainty related to natural disaster on the Reykjanes peninsula.The cost/income ratio was 33.6%, compared with 33.3% in the first quarter of 2023.The total capital ratio was 24.9% at the end of the period. The total capital requirement of the Financial Supervisory Authority of the Central Bank of Iceland is 20.7%.In March, Landsbankinn finalised the sale of green bonds in the amount of EUR 300 million, with subscriptions coming in at more than six times the size of the issuance.Also in Ma
Conqueror Freight Network brings together more than 120 logistics leaders from all over the world in Bali to celebrate its 10th Annual Meeting2.5.2024 14:08:15 CEST | Press release
Conqueror seized this special anniversary as an opportunity to recognize founding members with an Awards Ceremony and to present its new web app, its new website and cutting-edge digital services Bali, 2nd May 2024: Conqueror’s networking and conference event, from the 21st to the 23rd of April, came to a successful close last Wednesday. Conqueror Freight Network hosted professional leaders from the freight forwarding industry to discuss the global logistics environment, the industry challenges and growth and the technological trends in freight forwarding. The meeting that took place at the Intercontinental Bali Resort in Bali, Indonesia was attended by more than 120 freight forwarders from over 60 countries, facilitating their company’s increase, expansion and networking. In order to mark the 10th edition of Conqueror’s in-person conference, they presented an award honoring longstanding members who have been integral to the network since its inception, making invaluable contributions
Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism2.5.2024 14:00:00 CEST | Press release
Designation reflects the seriousness of the disease and the potential for eneboparatide to address the urgent need for new treatment options that address key treatment goals in hypoparathyroidism LYON, France and CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that eneboparatide, its lead therapeutic peptide candidate in Phase 3 development for the treatment of hypoparathyroidism, has been granted fast track designation by the U.S. Food and Drug Administration (FDA). The FDA’s Fast Track process is designed to facilitate the development and expedite the review of new drugs to treat serious conditions with unmet medical needs, with the goal of introducing new treatment options to patients faster. “We believe FDA’s granting of fast track designation to eneboparatide reflects the agency’s recognition of the significant unmet needs that persist among pa